Skip to main content

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Projects

RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2

IP: Pere Soler Palacín
Collaborators: Miriam Gonzalez Amores, Tamara Del Rio Higueras, Ariadna Martín Balcells, Amaia Latasa Arrazubi, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo, Maria Soraya Badia Ventura
Funding agency: EUROPEAN COMMISSION
Funding: 475000
Reference: RBDCOV_HE-HLTH-CORONA2021
Duration: 01/12/2021 - 31/05/2025

Related news

So far, 240 volunteers have been recruited within all the centres set to join adolescents’ clinical trial (named HH3) to test the efficacy, tolerability, and safety of the BIMERVAX® COVID-19 vaccine in adolescents aged 12 to 17.

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

The study, which is part of the European RECOMB project, is currently recruiting volunteers.

Related professionals

Jorge Daniel Fernández Núñez

Jorge Daniel Fernández Núñez

Read more
Tomás Van Eeckhout Carter

Tomás Van Eeckhout Carter

Administration and Management
Donation and transplantation of organs, tissues and cells
Read more
Elida Teresa Mercado Santis

Elida Teresa Mercado Santis

Read more
Cristina Padros Fornieles

Cristina Padros Fornieles

Research technician
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.